PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19374865-9	2009	We also demonstrate for the first time that the COX-2 inhibitor rofecoxib can reduce 6-keto PGF1alpha production by both enzymatic inhibition and transcriptional repression.	6-Ketoprostaglandin F1 alpha	85-101	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	48-53	
19040046-12	2008	In the cases with both COX-2 -765GG and PGIS CC genotypes, the serum 6-keto-PGF1alpha levels was lower than that of others (P < 0.05).	6-Ketoprostaglandin F1 alpha	69-85	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	23-28	
19040046-14	2008	Populations with both COX-2 -765GG and PGIS CC genotypes were more at risk with MI than others which might be resulted from the decreased serum 6-keto-PGF1alpha concentration.	6-Ketoprostaglandin F1 alpha	144-160	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	22-27	
17143555-10	2007	Diosgenin increased COX-2 activity resulting in PGE2 and 6-keto-PGF1alpha overproduction in human RA FLS.	6-Ketoprostaglandin F1 alpha	57-73	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	20-25	
11926591-5	2002	The activity of COX-2 was assessed by measuring the production of 6-keto-prostaglandin F1alpha in the presence of exogenous arachidonic acids (10 microM, 10 min) by enzyme immunoassay.	6-Ketoprostaglandin F1 alpha	66-94	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	16-21	
11950805-8	2002	Injured tissues treated with the selective COX-1 inhibitor SC-560 (5x10(-6) M) or the COX-2 inhibitor NS-398 (5x10(-6) M) recovered to control levels of resistance within three hours, associated with significant elevations of PGE and 6-keto-PGF1alpha compared with untreated tissues.	6-Ketoprostaglandin F1 alpha	234-250	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	86-91	
12664572-0	2002	Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue.	6-Ketoprostaglandin F1 alpha	49-66	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	12-17	
32485532-4	2020	COX-2 inhibitory activity was further demonstrated by the inhibition of the accumulation of 6-keto-PGF1alpha, a metabolite of COX-2 products in two cancer cell lines.	6-Ketoprostaglandin F1 alpha	92-108	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	0-5	
32485532-4	2020	COX-2 inhibitory activity was further demonstrated by the inhibition of the accumulation of 6-keto-PGF1alpha, a metabolite of COX-2 products in two cancer cell lines.	6-Ketoprostaglandin F1 alpha	92-108	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	126-131	
29483877-10	2018	There is a decrease in the percentage of AA, associated with an increase of PLA2, COX2/TXA2R, CYP450 4A, and 5-LOX which leads to a greater synthesis of PGE2 than of 6-keto-PGF1alpha, thus contributing to the formation of the aortic aneurysm.	6-Ketoprostaglandin F1 alpha	166-182	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	82-86